Next Article in Journal
Physicochemical Properties of Dried and Powdered Pear Pomace
Next Article in Special Issue
Recent Advances in Antibacterial Coatings to Combat Orthopedic Implant-Associated Infections
Previous Article in Journal
Hyaluronan: Sources, Structure, Features and Applications
Previous Article in Special Issue
γ-Cyclodextrin Metal-Organic Frameworks: Do Solvents Make a Difference?
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Multiscale Modeling of Macromolecular Interactions between Tau-Amylin Oligomers and Asymmetric Lipid Nanodomains That Link Alzheimer’s and Diabetic Diseases

1
Neuroscience Department, Trinity University, San Antonio, TX 78212, USA
2
Physics Department, Trinity University, San Antonio, TX 78212, USA
*
Author to whom correspondence should be addressed.
Molecules 2024, 29(3), 740; https://doi.org/10.3390/molecules29030740
Submission received: 26 December 2023 / Revised: 17 January 2024 / Accepted: 3 February 2024 / Published: 5 February 2024

Abstract

The molecular events of protein misfolding and self-aggregation of tau and amylin are associated with the progression of Alzheimer’s and diabetes, respectively. Recent studies suggest that tau and amylin can form hetero-tau-amylin oligomers. Those hetero-oligomers are more neurotoxic than homo-tau oligomers. So far, the detailed interactions between the hetero-oligomers and the neuronal membrane are unknown. Using multiscale MD simulations, the lipid binding and protein folding behaviors of hetero-oligomers on asymmetric lipid nanodomains or raft membranes were examined. Our raft membranes contain phase-separated phosphatidylcholine (PC), cholesterol, and anionic phosphatidylserine (PS) or ganglioside (GM1) in one leaflet of the lipid bilayer. The hetero-oligomers bound more strongly to the PS and GM1 than other lipids via the hydrophobic and hydrophilic interactions, respectively, in the raft membranes. The hetero-tetramer disrupted the acyl chain orders of both PC and PS in the PS-containing raft membrane, but only the GM1 in the GM1-containing raft membrane as effectively as the homo-tau-tetramer. We discovered that the alpha-helical content in the heterodimer was greater than the sum of alpha-helical contents from isolated tau and amylin monomers on both raft membranes, indicative of a synergetic effect of tau-amylin interactions in surface-induced protein folding. Our results provide new molecular insights into understanding the cross-talk between Alzheimer’s and diabetes.
Keywords: protein-lipid binding; anionic lipid nanodomains; protein folding; Alzheimer’s and diabetics crosstalk; amyloid-raft structures; lipid raft; neuronal membrane leaflets; oligomers protein-lipid binding; anionic lipid nanodomains; protein folding; Alzheimer’s and diabetics crosstalk; amyloid-raft structures; lipid raft; neuronal membrane leaflets; oligomers

Share and Cite

MDPI and ACS Style

Santos, N.; Segura, L.; Lewis, A.; Pham, T.; Cheng, K.H. Multiscale Modeling of Macromolecular Interactions between Tau-Amylin Oligomers and Asymmetric Lipid Nanodomains That Link Alzheimer’s and Diabetic Diseases. Molecules 2024, 29, 740. https://doi.org/10.3390/molecules29030740

AMA Style

Santos N, Segura L, Lewis A, Pham T, Cheng KH. Multiscale Modeling of Macromolecular Interactions between Tau-Amylin Oligomers and Asymmetric Lipid Nanodomains That Link Alzheimer’s and Diabetic Diseases. Molecules. 2024; 29(3):740. https://doi.org/10.3390/molecules29030740

Chicago/Turabian Style

Santos, Natalia, Luthary Segura, Amber Lewis, Thuong Pham, and Kwan H. Cheng. 2024. "Multiscale Modeling of Macromolecular Interactions between Tau-Amylin Oligomers and Asymmetric Lipid Nanodomains That Link Alzheimer’s and Diabetic Diseases" Molecules 29, no. 3: 740. https://doi.org/10.3390/molecules29030740

APA Style

Santos, N., Segura, L., Lewis, A., Pham, T., & Cheng, K. H. (2024). Multiscale Modeling of Macromolecular Interactions between Tau-Amylin Oligomers and Asymmetric Lipid Nanodomains That Link Alzheimer’s and Diabetic Diseases. Molecules, 29(3), 740. https://doi.org/10.3390/molecules29030740

Article Metrics

Back to TopTop